All Updates

All Updates

icon
Filter
Product updates
Mycorena discontinues Swedish factory project; shifts focus to circular production model
Plant-based Meat
Jun 13, 2024
This week:
Product updates
Hexagon unveils Advanced Compensation for metal 3D printing
Additive Manufacturing
Yesterday
Funding
Eden AI raises EUR 3 million in seed funding to accelerate product development
Generative AI Infrastructure
Nov 21, 2024
M&A
Wiz acquires Dazz to expand cloud security remediation capabilities
Next-gen Cybersecurity
Nov 21, 2024
Partnerships
Immutable partners with Altura to enhance Web3 game development and marketplace solutions
Web3 Ecosystem
Nov 21, 2024
Funding
OneCell Diagnostics raises USD 16 million in Series A funding to enhance cancer diagnostics
Precision Medicine
Nov 21, 2024
Partnerships
BioLineRx and Ayrmid partner to license and commercialize APHEXDA across multiple indications
Precision Medicine
Nov 21, 2024
Product updates
SOPHiA GENETICS announces global launch of MSK-IMPACT powered with SOPHiA DDM
Precision Medicine
Nov 21, 2024
Product updates
Biofidelity launches Aspyre Clinical Test for lung cancer detection
Precision Medicine
Nov 21, 2024
Partnerships
Spendesk partners with Adyen to enhance SMB spend management with banking-as-a-service solution
Business Expense Management
Nov 21, 2024
M&A
Mews acquires Swedish RMS provider Atomize to enhance Hospitality Cloud platform
Travel Tech
Nov 21, 2024
Plant-based Meat

Plant-based Meat

Jun 13, 2024

Mycorena discontinues Swedish factory project; shifts focus to circular production model

Product updates

  • Mycorena, a Swedish alternative protein producer, has discontinued its planned factory project in Sweden for Promyc, its principal mycoprotein ingredient. The company claims that a market shift and decreased investor interest in high-capital investment projects have led to this decision.

  • Mycorena will now shift its focus to a B2B2C approach, utilizing a sustainable circular upcycling production model by capitalizing on its Gothenburg demo plant's capacity, maintaining existing collaborations, and searching for new opportunities with private brands and foodservice entities. The company expects the Gothenburg plant will produce enough mycoprotein ingredients for up to 500 tons of consumer products.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.